Researchers at the National Institutes of Health have developed an experimental vaccine that could, theoretically, eliminate malaria from entire geographic regions, by eradicating the malaria parasite from an area’s mosquitoes.
An emulsion of olive oil, egg yolk and glycerine might be just the recipe to keep heart patients away from the operating room and cardiac bypass surgery.
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), announced an early end to two clinical trials of adult male circumcision because an interim review of trial data revealed that medically performed circumcision significantly reduces a man’s risk of acquiring HIV through heterosexual intercourse.
A CIHR-funded randomized controlled trial conducted in Kenya has demonstrated that male circumcision is an effective measure for reducing HIV incidence in young men.
A University of Illinois at Chicago study has been stopped early due to dramatic preliminary results indicating that medical circumcision reduces the risk of acquiring HIV during heterosexual intercourse by 53 percent.
A group of researchers, funded in part through two of NIAID’s Regional Centers of Excellence for Biodefense and Emerging Infectious Diseases, has provided a rare atomic glimpse of the initial step one of botulinu’s toxins takes to gain entry into human neurons. In an advanced online publication of the journal Nature, the scientists show structurally how botulinum neurotoxin B (one of seven toxins the bacterium produces) recognizes receptors on the surface of human neurons.
The widely used breast cancer drug tamoxifen (Nolvadex?), which can become less effective over time, might retain its full strength indefinitely if used along with a second drug, according to new research in mice conducted by investigators from the National Cancer Institute (NCI), part of the National Institutes of Health, and their partners. The results appear in the December 11, 2006, issue of Cancer Cell.
Back-to-back papers published online this week in Nature Genetics reveal important new details about the genetic variability of the malaria parasite and provide new clues for how it causes disease.
Researchers are advancing against a rare, deadly lung disease (related to hormones) that no one had even heard of a decade ago. The disease targets only women, striking them down during their childbearing years. It can be triggered by pregnancy, progresses rapidly, and often results in death within 10 years.
While investigating a fungus known to cause an infection in people with AIDS, two grantees of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), unexpectedly discovered a potential strategy for treating metastatic melanoma, one of the deadliest forms of skin cancer.